DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Virtual Event

2025 年 05 月 15 日 9:00 上午 - 2025 年 05 月 15 日 2:30 下午

(British Summer Time)

4051 Basel, Switzerland

UK National QPPV Forum

概览

 

Adapting to Regulatory Evolution: Join Us at the UK National QPPV Forum!

The Windsor Framework officially came into effect in January 2025, and as professionals—from pharma companies, regulatory bodies, consultants, and auditors—you are now in the process of implementing it. As you navigate this transition, it’s crucial to share experiences and seek expert guidance on the implementation process. This forum provides a unique opportunity to address the challenges you’ve encountered in the initial months of rollout. 

At this year's forum, we will facilitate meaningful discussions on practical issues, including small group sessions where you can ask questions and receive targeted solutions to your specific challenges. As the national UK landscape continues to evolve, this forum will also provide updates on key developments, including: 

  • Windsor Framework – Implementation strategies
  • MHRA – Inspection priorities
  • Clinical Trial Regulation (CTACR) & Post-Market Surveillance (PMS) – Latest updates for medical devices
  • AI in Device Vigilance – Opportunities & challenges

Engage in expert-led breakout discussions, gain insights from MHRA representatives, and leave with actionable compliance strategies.

Don't miss this opportunity to stay informed & prepared!

谁应该参加?

  • UK or EU QPPVs
  • UK NCPs
  • Deputy QPPVs
  • Regulators
  • Pharmacovigilance Consultants
  • Directors of Pharmacovigilance Oversight and Standards
  • Drug Safety Managers/Leaders
  • Auditors

 

Need Approval in Order to Attend?

Download and fill out our justification letter to advocate to your supervisor why this is a must-attend event.

 

Download letter (CLICK HERE)

项目委员会

  • Elspeth  McIntosh, MBA, RN
    Elspeth McIntosh, MBA, RN Director
    Castle Pharmacovigilance Ltd, United Kingdom
  • Sophie  Radicke, MSC
    Sophie Radicke, MSC Head of GPvP and Senior Pharmacovigilance Inspector
    Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
  • Louise  Woodward, PHD
    Louise Woodward, PHD UK QPPV and Local Safety Responsible
    Roche Products Ltd, United Kingdom
  • Helen  Fiddes
    Helen Fiddes Head of Country Pharmacovigilance, UK and Ireland
    Bristol-Myers Squibb, United Kingdom
  • Lauren  East
    Lauren East Head, Pharmacovigilance UK
    Abbvie, United Kingdom
  • Claudia   Ferreira
    Claudia Ferreira Scientific Programs Manager
    DIA, Switzerland

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。